Tissue plasminogen activator in trabecular meshwork attenuates steroid induced outflow resistance in mice

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Kumar, Sandeep ^a,b   Shah, Shaily ^b,c   Tang, Hai Michael ^a   Smith, Matthew ^d   Borrás, Teresa ^d   Danias, John ^a,b  

^a Downstate Health Sciences University   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE 3; COMPLEMENTARY DNA; GELATINASE A; GELATINASE B; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; STEROID; TISSUE PLASMINOGEN ACTIVATOR; TRIAMCINOLONE ACETONIDE;

ADENOVIRIDAE; ANIMAL EXPERIMENT; ANIMAL TISSUE; AQUEOUS HUMOR OUTFLOW; ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; INTRAOCULAR PRESSURE; MMP 13 GENE; MMP 2 GENE; MMP 9 GENE; MOUSE; NONHUMAN; PAI 1 GENE; PLAT GENE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SUSPENSION; TRABECULAR MESHWORK; UPREGULATION; VIRAL GENE DELIVERY SYSTEM; VIRUS GENOME; ANIMAL; AQUEOUS HUMOR; C57BL MOUSE; DRUG EFFECTS; GENETICS; METABOLISM; PHYSIOLOGY; SHEEP;

ANIMALIA; MUS; OVIS ARIES;

ADENOVIRIDAE; ANIMALS; AQUEOUS HUMOR; FEMALE; GENE EXPRESSION REGULATION; INTRAOCULAR PRESSURE; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE, INBRED C57BL; PLASMINOGEN ACTIVATOR INHIBITOR 1; SHEEP; STEROIDS; TISSUE PLASMINOGEN ACTIVATOR; TRABECULAR MESHWORK; TRIAMCINOLONE ACETONIDE;

EID: 84902478231     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072447     Document Type: Article

References (42)

1. Tripathi BJ, Geanon JD, Tripathi RC (1987) Distribution of tissue plasminogen activator in human and monkey eyes. An immunohistochemical study. Ophthalmology 94: 1434-1438. PubMed: 3120076.
2. Geanon JD, Tripathi BJ, Tripathi RC, Barlow GH (1987) Tissue plasminogen activator in avascular tissues of the eye: a quantitative study of its activity in the cornea, lens, and aqueous and vitreous humors of dog, calf, and monkey. Exp Eye Res 44: 55-63. doi:10.1016/S0014-4835(87)80025-8. PubMed: 3104075.
3. Smalley DM, Fitzgerald JE, Taylor DM, Cone RE, O'Rourke J (1994) Tissue plasminogen activator activity in human aqueous humor. Invest Ophthalmol Vis Sci 35: 48-53. PubMed: 8300363.
4. Murphy G, Atkinson S, Ward R, Gavrilovic J, Reynolds JJ (1992) The role of plasminogen activators in the regulation of connective tissue metalloproteinases. Ann N Y Acad Sci 667: 1-12. doi:10.1111/j. 1749-6632.1992.tb51590.x.
5. Bradley JM, Vranka J, Colvis CM, Conger DM, Alexander JP et al. (1998) Effect of matrix metalloproteinases activity on outflow in perfused human organ culture. Invest Ophthalmol Vis Sci 39: 2649-2658. PubMed: 9856774.
6. Keller KE, Aga M, Bradley JM, Kelley MJ, Acott TS (2009) Extracellular matrix turnover and outflow resistance. Exp Eye Res 88: 676-682. doi: 10.1016/j.exer.2008.11.023. PubMed: 19087875.
7. Matrisian LM (1990) Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 6: 121-125. doi: 10.1016/0168-9525(90)90126-Q. PubMed: 2132731.
8. Jones R 3rd, Rhee DJ (2006) Corticosteroid-induced ocular hypertension and glaucoma: a brief review and update of the literature. Curr Opin Ophthalmol 17: 163-167. PubMed: 16552251.
9. Kersey JP, Broadway DC (2006) Corticosteroid-induced glaucoma: a review of the literature. Eye (Lond) 20: 407-416. doi:10.1038/sj.eye. 6701895. PubMed: 15877093.
10. Becker B, Mills DW (1963) Corticosteroids and Intraocular Pressure. Arch Ophthalmol 70: 500-507. doi:10.1001/archopht. 1963.00960050502012. PubMed: 14078872.
11. Armaly MF (1963) Effect of Corticosteroids on Intraocular Pressure and Fluid Dynamics. I. Eff Dexamethasone Norm Eye Arch Ophthalmol 70: 482-491.
12. Armaly MF (1963) Effect of Corticosteroids on Intraocular Pressure and Fluid Dynamics. Ii. Eff Dexamethasone Glaucomatous Eye Arch Ophthalmol 70: 492-499.
13. Rohen JW, Linnér E, Witmer R (1973) Electron microscopic studies on the trabecular meshwork in two cases of corticosteroid-glaucoma. Exp Eye Res 17: 19-31. doi:10.1016/0014-4835(73)90164-4. PubMed: 4356557.
14. Johnson D, Gottanka J, Flügel C, Hoffmann F, Futa R et al. (1997) Ultrastructural changes in the trabecular meshwork of human eyes treated with corticosteroids. Arch Ophthalmol 115: 375-383. doi: 10.1001/archopht.1997.01100150377011. PubMed: 9076211.
15. Roll P, [!(surname)!] (1979) Electronmicroscopic investigation of the trabecular meshwork in cortisonglaucoma. Klin Monbl Augenheilkd 174: 421-428. PubMed: 480814.
16. Snyder RW, Stamer WD, Kramer TR, Seftor RE (1993) Corticosteroid treatment and trabecular meshwork proteases in cell and organ culture supernatants. Exp Eye Res 57: 461-468. PubMed: 8282032.
17. el-Shabrawi Y, Eckhardt M, Berghold A, Faulborn J, Auboeck L et al. (2000) Synthesis pattern of matrix metalloproteinases (MMPs) and inhibitors (TIMPs) in human explant organ cultures after treatment with latanoprost and dexamethasone. Eye (Lond) 14(3A): 375-383. doi: 10.1038/eye.2000.92. PubMed: 11027004.
18. Seftor RE, Stamer WD, Seftor EA, Snyder RW (1994) Dexamethasone decreases tissue plasminogen activator activity in trabecular meshwork organ and cell cultures. J Glaucoma 3: 323-328. PubMed: 19920617.
19. Kumar S, Shah S, Deutsch ER, Tang HM, Danias J. (2013) Triamcinolone acetonide decreases outflow facility in C57BL/6 mouse eyes. Invest Ophthalmol Vis Sci 54: 1280-1287. doi:10.1167/iovs. 12-11223. PubMed: 23322580.
20. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW et al. (1998) A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A 95: 2509-2514. doi:10.1073/pnas.95.5.2509. PubMed: 9482916.
21. Spiga MG, Borrás T. (2010) Development of a gene therapy virus with a glucocorticoid-inducible MMP1 for the treatment of steroid glaucoma. Invest Ophthalmol Vis Sci 51: 3029-3041. doi:10.1167/iovs.09-4918. PubMed: 20089870.
22. Danias J, Kontiola AI, Filippopoulos T, Mittag T (2003) Method for the noninvasive measurement of intraocular pressure in mice. Invest Ophthalmol Vis Sci 44: 1138-1141. doi:10.1167/iovs.02-0553. PubMed: 12601041.
23. Nissirios N, Goldblum D, Rohrer K, Mittag T, Danias J (2007) Noninvasive determination of intraocular pressure (IOP) in nonsedated mice of 5 different inbred strains. J Glaucoma 16: 57-61. doi:10.1097/IJG.0b013e31802b3547. PubMed: 17224751.
24. Clark AF, Wilson K, McCartney MD, Miggans ST, Kunkle M et al. (1994) Glucocorticoid-induced formation of cross-linked actin networks in cultured human trabecular meshwork cells. Invest Ophthalmol Vis Sci 35: 281-294. PubMed: 8300356.
25. Wilson K, McCartney MD, Miggans ST, Clark AF (1993) Dexamethasone induced ultrastructural changes in cultured human trabecular meshwork cells. Curr Eye Res 12: 783-793. doi: 10.3109/02713689309020383. PubMed: 8261790.
26. Borrás T, Rowlette LL, Erzurum SC, Epstein DL (1999) Adenoviral reporter gene transfer to the human trabecular meshwork does not alter aqueous humor outflow. Relevance for potential gene therapy of glaucoma. Gene Ther 6: 515-524. doi:10.1038/sj.gt.3300860. PubMed: 10476211.
27. Borrás T, Gabelt BT, Klintworth GK, Peterson JC, Kaufman PL (2001) Non-invasive observation of repeated adenoviral GFP gene delivery to the anterior segment of the monkey eye in vivo. J Gene Med 3: 437-449. doi:10.1002/jgm.210. PubMed: 11601757.
28. Masos T, Dan JA, Miskin R (2000) Plasminogen activator inhibitor-1 mRNA is localized in the ciliary epithelium of the rodent eye. Invest Ophthalmol Vis Sci 41: 1006-1011. PubMed: 10752934.
29. Fuchshofer R, Welge-Lussen U, Lütjen-Drecoll E (2003) The effect of TGF-beta2 on human trabecular meshwork extracellular proteolytic system. Exp Eye Res 77: 757-765. doi:10.1016/S0014-4835(03)00220-3. PubMed: 14609564.
30. Dan J, Belyea D, Gertner G, Leshem I, Lusky M et al. (2005) Plasminogen activator inhibitor-1 in the aqueous humor of patients with and without glaucoma. Arch Ophthalmol 123: 220-224. doi:10.1001/archopht.123.2.220. PubMed: 15710819.
31. Stamer WD, Hoffman EA, Kurali E, Krauss AH. (2013) Unique response profile of trabecular meshwork cells to the novel selective glucocorticoid receptor agonist, GW870086X. Invest Ophthalmol Vis Sci 54: 2100-2107. doi:10.1167/iovs.12-11298. PubMed: 23462748.
32. Rönkkö S, Rekonen P, Kaarniranta K, Puustjärvi T, Teräsvirta M et al. (2007) Matrix metalloproteinases and their inhibitors in the chamber angle of normal eyes and patients with primary open-angle glaucoma and exfoliation glaucoma. Graefes Arch Clin Exp Ophthalmol 245: 697-704. doi:10.1007/s00417-006-0440-1. PubMed: 17028863.
33. Määttä M, Tervahartiala T, Harju M, Airaksinen J, Autio-Harmainen H et al. (2005) Matrix metalloproteinases and their tissue inhibitors in aqueous humor of patients with primary open-angle glaucoma, exfoliation syndrome, and exfoliation glaucoma. J Glaucoma 14: 64-69. doi:10.1097/01.ijg.0000145812.39224.0a. PubMed: 15650607.
34. Wang X, Lee SR, Arai K, Tsuji K, Rebeck GW et al. (2003) Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator. Nat Med 9: 1313-1317. doi:10.1038/nm926. PubMed: 12960961.
35. Ning M, Furie KL, Koroshetz WJ, Lee H, Barron M et al. (2006) Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke. Neurology 66: 1550-1555. doi: 10.1212/01.wnl.0000216133.98416.b4. PubMed: 16717217.
36. Tsuji K, Aoki T, Tejima E, Arai K, Lee SR et al. (2005) Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia. Stroke 36: 1954-1959. doi: 10.1161/01.STR.0000177517.01203.eb. PubMed: 16051896.
37. Marshall GE, Konstas AG, Lee WR (1991) Immunogold ultrastructural localization of collagens in the aged human outflow system. Ophthalmology 98: 692-700. PubMed: 2062503.
38. Mayne R, Brewton RG (1993) New members of the collagen superfamily. Curr Opin Cell Biol 5: 883-890. doi: 10.1016/0955-0674(93)90039-S. PubMed: 8240831.
39. Zhou L, Li Y, Yue BY (1998) Glucocorticoid effects on extracellular matrix proteins and integrins in bovine trabecular meshwork cells in relation to glaucoma. Int J Mol Med 1: 339-346. PubMed: 9852235.
40. Hsiao Y, Zou T, Ling CC, Hu H, Tao XM et al. (2008) Disruption of tissue-type plasminogen activator gene in mice aggravated liver fibrosis. J Gastroenterol Hepatol 23: e258-e264. doi:10.1111/j. 1440-1746.2008.05447.x. PubMed: 17944888.
41. Nakagami Y, Abe K, Nishiyama N, Matsuki N (2000) Laminin degradation by plasmin regulates long-term potentiation. J Neurosci 20: 2003-2010. PubMed: 10684901.
42. Bonnefoy A, Legrand C (2000) Proteolysis of subendothelial adhesive glycoproteins (fibronectin, thrombospondin, and von Willebrand factor) by plasmin, leukocyte cathepsin G, and elastase. Thromb Res 98: 323-332. doi:10.1016/S0049-3848(99)00242-X. PubMed: 10822079.